...
首页> 外文期刊>Molecular Carcinogenesis >New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin.
【24h】

New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin.

机译:新近交SENCAR小鼠品系对皮肤中的乳头状瘤和鳞状细胞癌的诱导敏感性增加。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

To develop mouse strains useful for studies of susceptibility and resistance to the induction of skin tumors, three new inbred SENCAR strains were independently derived by random inbreeding of outbred SENCAR mice. Characterization of these mice for sensitivity to skin tumor development indicated that mice of all three strains displayed increased sensitivity to initiation by 7,12-dimethylbenz[a]anthracene (DMBA), urethane, or N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and promotion by 12-O-tetradecanoylphorbol-13-acetate (TPA). Promotion by mezerein as well as carcinogenesis by repeated treatment with DMBA or MNNG produced papillomas with a high frequency of conversion to squamous cell carcinomas (SCCs). Compared with outbred SENCAR mice, development of both squamous papillomas and carcinomas was increased at least two-fold by all protocols tested. The F1 hybrid between SENCARA/Pt males and resistant BALB/cAnPt females was resistant to the induction of both papillomas and SCCs after initiation by 2 microg of DMBA and promotion by 20 weekly applications of 2 microg of TPA. Papillomas developed in all of the SENCARA/Pt mice, none of the BALB/cAnPt mice, and 12% of the F1 progeny. Thus, at these doses of initiator and promoter, resistance was incompletely dominant in the F1 hybrid. However, the responsiveness of the F1 mice could be increased substantially by increasing the dose of the promoter.
机译:为了开发可用于研究对皮肤肿瘤的敏感性和耐药性的小鼠品系,通过随机繁殖近交SENCAR小鼠独立地衍生出三种新的近交SENCAR品系。这些小鼠对皮肤肿瘤发展的敏感性的表征表明,所有三种菌株的小鼠均显示出对7,12-二甲基苯并[a]蒽(DMBA),氨基甲酸酯或N-甲基-N'-硝基-N-的引发敏感性提高。亚硝基胍(MNNG)和由12-O-十四烷酰佛波醇13-乙酸酯(TPA)促进。甲美蝶呤的促进作用以及通过DMBA或MNNG的重复治疗引起的癌变产生了高频率转化为鳞状细胞癌(SCC)的乳头状瘤。与远亲SENCAR小鼠相比,所有测试方案均使鳞状乳头状瘤和癌的发展至少增加了两倍。 SENCARA / Pt雄性与抗性BALB / cAnPt雌性之间的F1杂种在通过2微克DMBA引发并通过每周20次应用2微克TPA促进后对乳头状瘤和SCC的诱导均具有抗性。乳头状瘤在所有SENCARA / Pt小鼠中发展,BALB / cAnPt小鼠均无,F1后代占12%。因此,在这些剂量的引发剂和启动子下,抗性在F1杂种中不完全占优势。但是,可以通过增加启动子的剂量来显着提高F1小鼠的反应能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号